31 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
technology, reputation, customer service and access to technical information.
We are currently focusing our clinical efforts on the use of botulinum … quality and price, product technology, reputation, customer service and access to technical information.
If approved, ABP-450 may face competition
8-K
EX-10.2
fc2qeb79 vcmnhrcqm
19 Mar 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.13
7yzusperxlo0tmlgkz
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-14.1
9pamyz g3
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.5
d56t3n
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.12
l1fqq8iw
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.11
x70ke925 z1ul5
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.1
5tb01uhk
27 Jul 23
Index to Financial Statements
5:28pm
DEFM14A
xfvtkih
12 May 23
Proxy related to merger
5:00pm
424B3
ncrxcci55 7s
12 May 23
Prospectus supplement
4:33pm